Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

From injections to pills: FDA approves first oral GLP-1 for type 2 diabetes

Almost 15 years after the approval of the first GLP-1 agonist, the US FDA has approved the first oral version of this treatment approach for type 2 diabetes. What are the benefits of a pill-based, rather than injectable version, of GLP-1 analogues for this patient population?


Go Top